" #Daraxonrasib is the 1st targeted therapy specifically approved for this form of #PancreaticCancer & inhibits a protein called RAS, a molecular switch which can get stuck “on,” driving growth of #CancerCells.": buff.ly/13RT42w

via @forbes.com
#cancer #pancreas #medication #treatment #healthcare

#Drug doubles life expectancy of pancreatic cancer patients 💊

The #FDA approved #daraxonrasib, from Revolution Medicines, after patients in a #Phase3 clinical trial lived twice as long as those on #chemotherapy. The drug was studied in #mice and #monkeys before #HumanTrials.

🔗 shorturl.at/BHYZd

#Bauchspeicheldrüsenkrebs #Daraxonrasib #Medikament
🌐 www.newsmart.ch

💊#FDA Drug Approvals — August 2026
🔬Notable first-in-class:
• #Daraxonrasib — RAS inhibitor
• Rusfertide — hepcidin mimetic
• Oveporexton — orexin signaling

🧬Other highlights: CELMoD/E3 ligase modulation, Activin A, and JAK/TYK2.